Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Grazoprevir / elbasvir highly effective in previously untreated hepatitis C

A 12-week course of the combination of grazoprevir and elbasvir cured 95% of previously untreated people with gentoypes 1, 4 or 6 hepatitis C infection, according to

Published
18 hours ago
By
Keith Alcorn
Sofosbuvir/ledipasvir plus ribavirin shows high cure rate for hepatitis C patients with advanced liver disease

An oral regimen of sofosbuvir/ledipasvir (Harvoni) and ribavirin taken for 12 or 24 weeks produced sustained virological response rates of 85-88% for genotype 1 or 4

Published
24 April 2015
By
Liz Highleyman
Merck HCV combination achieves 90% cure in advanced cirrhosis

A 12-week course of treatment with two direct-acting antivirals in development by Merck cured hepatitis C infection in 90% of people with very advanced cirrhosis and at

Published
23 April 2015
By
Keith Alcorn
Merck HCV combination effective after failure of first generation of direct-acting antivirals

A 12-week course of treatment with two direct-acting antivirals in development by Merck  plus ribavirin cured 95% of people with hepatitis C who had experienced failure of

Published
23 April 2015
By
Keith Alcorn
EASL Recommendations on Treatment of Hepatitis C 2015

These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the optimal management of patients with acute and chronic HCV infections.

Published
23 April 2015
From
EASL
Gilead uses Georgia as free-drug testbed for hepatitis C elimination

Gilead Sciences is seeking to convince governments and multilateral agencies worldwide that hepatitis C can be eliminated with a demonstration project in Georgia offering free drugs to all those who need them.

Published
23 April 2015
From
Reuters
Report: Hepatitis C in Eastern Europe and Central Asia: Epidemic and Response

The purpose of this report is to provide an overview of some of the key aspects of the hepatitis C (HCV) epidemic and response in Eastern Europe and Central Asia (EECA). It is also intended to outline tools and opportunities for civil society (CS) and community-based groups and individuals working on expanding access to HCV treatment in the region.

Published
23 April 2015
From
EATG
Many European countries ill-prepared to prevent and control the spread of viral hepatitis

Many countries in the World Health Organization European Region are facing limitations in conducting chronic viral hepatitis disease surveillance, assessing the burden of disease and measuring the impact of interventions, according to results revealed today at The International Liver Congress™ 2015.

Published
23 April 2015
From
Eurekalert Medicine & Health
HCV viral load levels during treatment and speed of decline do not predict cure with interferon-free therapy

Direct-acting antiviral regimens containing sofosbuvir (Sovaldi) and the drugs in Viekirax/Exviera were highly effective regardless of how soon hepatitis C viral load became undetectable after starting treatment, according to

Published
23 April 2015
By
Liz Highleyman
Cancer drug shows promise as cure for hepatitis B

A potential cure for hepatitis B virus infections has been found with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models. Australian patients are now the first in the world to have access to the potential treatment -- a combination of an antiviral drug and an anti-cancer drug -- which is in phase 1/2a clinical trials.

Published
21 April 2015
From
Science Daily
← First12345...163Next →

Filter by country